Radiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Radiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey
J Neurointerv Surg. 2021 Oct;13(10):946-950. doi: 10.1136/neurintsurg-2020-016784. Epub 2020 Dec 3.
We report our initial experience with the CatchView (CV) thrombectomy device in patients with acute ischemic stroke (AIS).
A retrospective analysis of 53 of 284 AIS patients (mean age 66.6±14.8 years, range 37-94) treated with a CV device between January 2019 and February 2020 was performed. The baseline characteristics (gender, age, comorbidities, National Institutes of Health Stroke Scale (NIHSS) score, intravenous tissue plasminogen activator (IV-tPA) administration, and occlusion localization) of these subjects were recorded. Modified Thrombolysis in Cerebral Ischemia (mTICI) scores of 2b and 3 were considered to indicate successful recanalization, and subjects with a modified Rankin Scale score of ≤2 on day 90 was considered a good clinical outcomes.
The mean NIHSS score was 12.3±3. Successful recanalization was achieved in 45 subjects (84.90%), and the rate of good clinical outcomes on day 90 was 43.39%. The secondary distal embolus rate was 5.66%. Symptomatic hemorrhage was observed in 3.77% of the subjects, and the mortality rate was 13.2%.
Mechanical thrombectomy devices include a wide array of endovascular tools for removing clots in AIS patients. In terms of successful recanalization and good clinical outcomes on day 90, our initial experience with the CV devices was encouraging.
我们报告了使用 CatchView（CV）血栓切除术装置治疗急性缺血性脑卒中（AIS）患者的初步经验。
回顾性分析了 2019 年 1 月至 2020 年 2 月期间使用 CV 装置治疗的 284 例 AIS 患者中的 53 例（平均年龄 66.6±14.8 岁，范围 37-94）。记录了这些患者的基线特征（性别、年龄、合并症、美国国立卫生研究院卒中量表（NIHSS）评分、静脉注射组织型纤溶酶原激活剂（IV-tPA）治疗和闭塞定位）。改良脑梗死溶栓（mTICI）评分 2b 和 3 被认为是成功再通的指标，90 天改良 Rankin 量表评分≤2 被认为是良好的临床结局。
平均 NIHSS 评分为 12.3±3。45 例（84.90%）患者实现了再通，90 天的良好临床结局率为 43.39%。继发性远端栓塞率为 5.66%。3.77%的患者出现症状性出血，死亡率为 13.2%。
机械血栓切除术装置包括多种血管内工具，用于清除 AIS 患者的血栓。就再通成功率和 90 天的良好临床结局而言，我们使用 CV 装置的初步经验令人鼓舞。
